Senior insider sale
TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.84M
22.35K shares
What this filing means
LIN ELIZABETH YEU plans to sell 22.35K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $1.84M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001959173-26-006758
Director
Since Dec 2021
22.35K
Shares to sell
$1.84M
Approx. market value
10.77K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Open Market Purchase
Cash
8/15/2023
4.75KOpen Market Purchase
Cash
9/14/2022
6.02KTotal acquired10.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2023 | Open Market Purchase Cash | 4.75K | — |
9/14/2022 | Open Market Purchase Cash | 6.02K | — |
| Total | 10.77K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5.39K
Market value
$431.0K
9/2/2026
—Completed
Units to sell
1.59K
Market value
$127.2K
9/2/2026
—Completed
Units to sell
4.60K
Market value
$339.8K
9/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.77K
Market value
$942.6K
9/4/2026
Total
Units
22.35K
Value
$1.84M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2026 | 5.39K | $431.0K | — | Completed |
9/2/2026 | 1.59K | $127.2K | — | Completed |
9/1/2026 | 4.60K | $339.8K | — | Completed |
| Planned — Approximate Date | ||||
9/4/2026 | 10.77K | $942.6K | NASDAQ | Planned |
| Total | 22.35K | $1.84M | ||